Aeterna Zentaris DPO Ratio 2011-2026 | AEZS

Annual DPO Ratio Aeterna Zentaris

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	34.4 K	90.8	107

All numbers in USD currency

Maximum	Minimum	Average
34.4 K	90.8	11.5 K

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
Alector ALEC	13.8	$ 2.11	-13.17 %	$ 217 M	USA
Axsome Therapeutics AXSM	529	$ 163.89	-	$ 8.15 B	USA
BridgeBio Pharma BBIO	399	$ 64.28	-3.31 %	$ 12.3 B	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
BioCardia BCDA	68.1 K	$ 1.37	5.81 %	$ 29 M	USA
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
BioMarin Pharmaceutical BMRN	245	$ 59.8	-3.13 %	$ 11.5 B	USA
Bristol-Myers Squibb Company BMY	94	$ 62.08	-0.46 %	$ 126 B	USA
Benitec Biopharma BNTC	-556	$ 10.93	0.23 %	$ 450 M	USA
Acorda Therapeutics ACOR	277	-	-24.86 %	$ 820 K	USA
BioXcel Therapeutics BTAI	2.52 K	$ 1.63	-2.4 %	$ 4.13 M	USA
Acasti Pharma ACST	4.39 K	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
AIkido Pharma AIKI	32.8 K	-	1.93 %	$ 17.4 M	USA
Albireo Pharma ALBO	1.59 K	-	-0.23 %	$ 916 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Catalyst Biosciences CBIO	18.8	$ 11.67	-3.47 %	$ 768 M	USA
Codexis CDXS	98.4	$ 0.99	-2.04 %	$ 72.7 M	USA